CUSIP: 29428V104
Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
93,611,465
-
Share change
-
+798,440
-
Total reported value
-
$1,503,407,182
-
Put/Call ratio
-
16%
-
Price per share
-
$16.06
-
Number of holders
-
157
-
Value change
-
+$17,627,121
-
Number of buys
-
103
-
Number of sells
-
54
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2020
-
Previous quarter:
Q1 2020
Recent filing periods for CUSIP 29428V104:
Institutional Holders of EPIZYME INC - COM (EPZM) as of Q2 2020
As of 30 Jun 2020,
EPIZYME INC - COM (EPZM) was held by
157 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
93,611,465 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, RP Management, LLC, Redmile Group, LLC, BlackRock Inc., VANGUARD GROUP INC, Palo Alto Investors LP, STATE STREET CORP, MPM Oncology Impact Management LP, VICTORY CAPITAL MANAGEMENT INC, and Rock Springs Capital Management LP.
This page lists
157
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.